Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.36−0.03 (-8.70%)
Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –
Evogene total assets
Total assets on the balance sheet at the end of each period.
Evogene's total assets was $13.44M at Jun 30, 2026. For fiscal 2025 it was $20.05M, down 49.7% from the year before. The highest annual figure on record is $95.99M in fiscal 2016.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.05M | -49.7% |
| FY2024 | Dec 31, 2024 | $39.86M | -22.0% |
| FY2023 | Dec 31, 2023 | $51.10M | -9.0% |
| FY2022 | Dec 31, 2022 | $56.13M | -26.4% |
| FY2021 | Dec 31, 2021 | $76.30M | +6.1% |
| FY2020 | Dec 31, 2020 | $71.92M | +0.8% |
| FY2019 | Dec 31, 2019 | $71.36M | +21.6% |
| FY2018 | Dec 31, 2018 | $58.69M | -24.4% |
| FY2017 | Dec 31, 2017 | $77.60M | -19.2% |
| FY2016 | Dec 31, 2016 | $95.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.44M | -67.2% |
| Q4 FY2025 | Dec 31, 2025 | $20.05M | -60.8% |
| Q2 FY2025 | Jun 30, 2025 | $33.93M | -36.4% |
| Q4 FY2024 | Dec 31, 2024 | $39.86M | -29.0% |
| Q2 FY2024 | Jun 30, 2024 | $40.97M | -27.7% |
| Q4 FY2023 | Dec 31, 2023 | $51.10M | -33.0% |
| Q2 FY2023 | Jun 30, 2023 | $53.34M | -39.1% |
| Q4 FY2022 | Dec 31, 2022 | $56.13M | -22.0% |
| Q2 FY2022 | Jun 30, 2022 | $56.66M | -7.3% |
| Q4 FY2021 | Dec 31, 2021 | $76.30M | +6.9% |
| Q2 FY2021 | Jun 30, 2021 | $87.54M | +49.1% |
| Q4 FY2020 | Dec 31, 2020 | $71.92M | -7.3% |
| Q2 FY2020 | Jun 30, 2020 | $61.11M | -36.3% |
| Q4 FY2019 | Dec 31, 2019 | $71.36M | – |
| Q4 FY2018 | Dec 31, 2018 | $58.69M | – |
| Q4 FY2017 | Dec 31, 2017 | $77.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $95.99M | – |
See a number that looks wrong?